Wu Chi-hong, Si Chong-wen, Tian Geng-shan, Yu Yan-yan, Xu Xiao-yuan, Wang Tai-ling
Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
Zhonghua Gan Zang Bing Za Zhi. 2007 Aug;15(8):577-81.
To study the correlations between clinical features and liver pathohistological changes of chronic hepatitis B virus (HBV) carriers and to discuss the factors which may influence the prognosis.
Ninety HBV carriers who had liver biopsies were enrolled in this study.
(1) The mean follow-up period of the patients was 118 weeks. (2) Fifty-four patients (60.0%) had G1 hepatitis and 21 (23.3%) had G2 hepatitis. The fibrosis stages were graded as S1(42) and S2(21). (3) There were significant age differences among S0, S1 and S2. (4) There were significant differences in aminotransferase levels between patients who had a normal liver histology and those who had mild hepatitis. (5) The grades of liver inflammation were not correlated with the titers of HBeAg and HBV DNA in sera. The stages of liver fibrosis were not correlated with the titers of HBVDNA in sera. Most of the HBeAg negative patients progressed to S2. (6) There were significant differences in spleen dimensions measured by ultrasonography between S0, S1 and S2 patients. (7) During the follow-up period serum aminotransferase (ALT) levels remained normal in 60 patients (group A); 22 patients had transient elevations (group B), and 8 patients had persistent increases (group C). There were significant differences of the ratios of S0 and S2 cases among patients in groups A, B and C. (8) Age and fibrosis stages were predictive factors of liver cirrhosis.
Most chronic HBV carriers had mild inflammatory histological changes in their livers and also had different degrees of liver fibrosis. This follow-up study shows that some of those carriers should have had antiviral therapy.
研究慢性乙型肝炎病毒(HBV)携带者的临床特征与肝脏病理组织学变化之间的相关性,并探讨可能影响预后的因素。
本研究纳入了90例接受肝脏活检的HBV携带者。
(1)患者的平均随访期为118周。(2)54例患者(60.0%)为G1级肝炎,21例(23.3%)为G2级肝炎。纤维化阶段分级为S1(42例)和S2(21例)。(3)S0、S1和S2组之间年龄差异有统计学意义。(4)肝脏组织学正常的患者与轻度肝炎患者的转氨酶水平差异有统计学意义。(5)肝脏炎症分级与血清中HBeAg和HBV DNA滴度无关。肝脏纤维化阶段与血清中HBV DNA滴度无关。大多数HBeAg阴性患者进展为S2级。(6)S0、S1和S2组患者超声测量的脾脏大小差异有统计学意义。(7)随访期间,60例患者(A组)血清转氨酶(ALT)水平保持正常;22例患者有短暂升高(B组),8例患者持续升高(C组)。A、B和C组患者中S0和S2病例的比例差异有统计学意义。(8)年龄和纤维化阶段是肝硬化的预测因素。
大多数慢性HBV携带者肝脏有轻度炎症组织学改变,也有不同程度的肝纤维化。这项随访研究表明,其中一些携带者应该接受抗病毒治疗。